In his State of the Union Speech President Obama called for support for ‘the same kind of research that led to the computer chip and the Internet.’ He rightfully implies that for several decades now the innovation story has been primarily focused on computers, software and communication. As the power of science, technology, and free … Continue reading “Open Source May be the Answer for Pharma and Biotech”
Author: Connie Wong
Connie Wong is partner and Chair of the Life Sciences Practice Group at Lee & Hayes. Connie has over 11 years of experience in strategically procuring and managing complex patent portfolios in the biotech and pharmaceutical areas. Connie provides creative and innovative IP solutions that align with her clients’ business objectives and gives them a competitive advantage in the marketplace.
Connie focuses on preparing and prosecuting patent applications in the US and foreign countries, managing worldwide patent portfolios, performing all aspects IP evaluations including due diligence analysis, freedom-to-operate analysis and opinion preparation. Connie also provides counsel on issues worldwide in IP transactions, drafts and negotiates IP license agreements for the use and transfer of patents and other IP rights, and conducts IP due diligence for alliances and financings. She offers a wide variety of expertise in many biotech and life sciences areas, including immunology, molecular biology, chemistry, biochemistry, small molecules, genomics, medical devices, diagnostic assays and drug delivery systems.
Connie holds a Ph.D. degree in immunology and was a postdoctoral research fellow at Memorial Sloan-Kettering Cancer Center in New York prior to transitioning to patent law. She holds a J.D. degree from Fordham University School of Law and was a patent agent at Fish & Neave (New York) and an associate at Ropes & Gray (New York) before joining Lee & Hayes in Seattle.